These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32501943)

  • 1. Intravenous Immunoglobulin for Inflammatory Myositis: Experience in a Tertiary Medical Center.
    Ohad M; Shemer A; Lavie I; Ozeri D; Shoenfeld Y; Kivity S
    J Clin Rheumatol; 2021 Dec; 27(8):e616-e621. PubMed ID: 32501943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
    Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use.
    Gandiga PC; Ghetie D; Anderson E; Aggrawal R
    Curr Rheumatol Rep; 2023 Aug; 25(8):152-168. PubMed ID: 37261663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
    Wang DX; Shu XM; Tian XL; Chen F; Zu N; Ma L; Wang GC
    Clin Rheumatol; 2012 May; 31(5):801-6. PubMed ID: 22274797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P
    Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Gordon PA; Winer JB; Hoogendijk JE; Choy EH
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD003643. PubMed ID: 22895935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
    Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G
    Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis.
    Dalakas MC
    Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis.
    Hoff LS; de Souza FHC; Miossi R; Shinjo SK
    Rheumatology (Oxford); 2022 Apr; 61(4):1579-1588. PubMed ID: 34302454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials.
    Dalakas MC
    Neurol Sci; 2003 Oct; 24 Suppl 4():S256-9. PubMed ID: 14598055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: A systematic review and meta-analysis.
    Xiong A; Qiang Y; Cao Y; Shuai Y; Chen H; Xiang Q; Hu Z; Song Z; Zhou S; Zhang Y; Cui H; Wang Y; Luo J; Shuai S; Yang Y
    Mod Rheumatol; 2023 Apr; 33(3):533-542. PubMed ID: 35660927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
    Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
    Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis.
    Galimberti F; Kooistra L; Li Y; Chatterjee S; Fernandez AP
    Clin Exp Dermatol; 2018 Dec; 43(8):906-912. PubMed ID: 29856076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical review of the role of intravenous immunoglobulins in idiopathic inflammatory myopathies.
    Anh-Tu Hoa S; Hudson M
    Semin Arthritis Rheum; 2017 Feb; 46(4):488-508. PubMed ID: 27908534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.